rs73487878
Variant names:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001013251.3(SLC3A2):c.253C>T(p.Leu85Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00384 in 1,589,912 control chromosomes in the GnomAD database, including 188 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 93 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 95 hom. )
Consequence
SLC3A2
NM_001013251.3 synonymous
NM_001013251.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.86
Genes affected
SLC3A2 (HGNC:11026): (solute carrier family 3 member 2) This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. The encoded transporter plays a role in regulation of intracellular calcium levels and transports L-type amino acids. Alternatively spliced transcript variants, encoding different isoforms, have been characterized. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 11-62881276-C-T is Benign according to our data. Variant chr11-62881276-C-T is described in ClinVar as [Benign]. Clinvar id is 789624.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0651 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC3A2 | NM_001013251.3 | c.253C>T | p.Leu85Leu | synonymous_variant | Exon 1 of 9 | ENST00000338663.12 | NP_001013269.1 | |
SLC3A2 | NM_001012662.3 | c.559C>T | p.Leu187Leu | synonymous_variant | Exon 4 of 12 | NP_001012680.1 | ||
SLC3A2 | NM_002394.6 | c.556C>T | p.Leu186Leu | synonymous_variant | Exon 4 of 12 | NP_002385.3 | ||
SLC3A2 | NM_001012664.3 | c.370C>T | p.Leu124Leu | synonymous_variant | Exon 2 of 10 | NP_001012682.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0195 AC: 2976AN: 152254Hom.: 93 Cov.: 32
GnomAD3 genomes
AF:
AC:
2976
AN:
152254
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00476 AC: 985AN: 206764Hom.: 27 AF XY: 0.00353 AC XY: 394AN XY: 111552
GnomAD3 exomes
AF:
AC:
985
AN:
206764
Hom.:
AF XY:
AC XY:
394
AN XY:
111552
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00217 AC: 3125AN: 1437540Hom.: 95 Cov.: 31 AF XY: 0.00185 AC XY: 1320AN XY: 712894
GnomAD4 exome
AF:
AC:
3125
AN:
1437540
Hom.:
Cov.:
31
AF XY:
AC XY:
1320
AN XY:
712894
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0195 AC: 2978AN: 152372Hom.: 93 Cov.: 32 AF XY: 0.0190 AC XY: 1413AN XY: 74510
GnomAD4 genome
AF:
AC:
2978
AN:
152372
Hom.:
Cov.:
32
AF XY:
AC XY:
1413
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at